Visit Red Revolution Media's online store for all your socialist, progressive and protest fashions. From t-shirts to cushions, there's something for everyone!


China: First Results Expected From Coronavirus Clinical Drug Trials

Leading Chinese doctors announced that the first coronavirus clinical trial of the HIV-treatment drug Lopinavir has finished at a conference in Beijing on Wednesday.

“The good news is that the first trial [from the] Lopinavir clinical trial is finished. The Chinese doctors will share the new results with WHO and the international society as soon as possible,” said Vice President of China-Japan Friendship Hospital, Cao Bin.

Dr Li Haichao, who works with Cao on clinical tests at the COVID-19 virus epicentre in Wuhan, suggested oxygen therapy to be an efficient treatment for patients whose conditions deteriorate into severe pneumonia and Acute Respiratory Distress Syndrome (ARDS).

Du Bin, Director of Medical ICU at Peking Union Medical College Hospital, suggested that the only way to “fight against the plague” was if everyone did their job, and urged the government to “to educate the general public about the disease and how to prevent [the disease]. And to coordinate and organise all the resources, including human resources and other equipment.”

According to the latest reports by the European Centre for Disease Prevention and Control (ECDC), at least 94,000 people have been infected by the COVID-19 so far and over 3,200 people have died. There are currently 80,270 cases confirmed on China’s mainland.



This website is not sponsored or endorsed by big business, corporations or billionaire oligarchs, we have no resources and no backing. We rely on you to keep going.

Our monthly expenses include hosting services, specialist website subscriptions and services, photo media subscriptions, newswire services, and marketing. We currently are unable to issue any payment to writers.

It is our hope that we will one day be able to be a people funded and maintained service who are uniquely positioned to give a voice to the voiceless without any influence from corporatism.

If you value our articles please consider a donation to ensure the continuation of our work. Thank you.



Sign up to our newsletter and follow us on social media to get the latest news, updates from Red Revolution Media.
You can unsubscribe at any time